Phase i sbir topic 359 title: device strategy for selective isolation of oncosomes and non-malignant exosomes 09/15/2017 - 06/14/2018 firm fixed price
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201700022C
- Awardee
-
Aethlon Medical Inc. UEI MUNVGHPLRV56
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,250
Award facts
- Opportunity
-
- PHS20171 Solicitation number
- Contract value 100% obligated
- $299,250.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92123, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $299,250 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $299,250 firm fixed price contract to Aethlon Medical Inc. (doing business as Aethlon) for Phase I Small Business Innovation Research (SBIR) research and development services related to a device prototype for isolating melanoma exosomes for diagnostics and treatment monitoring. This contract was not set aside for any socioeconomic category. Aethlon Medical Inc. is a for-profit medical device company that creates products for cancer, infectious disease, and other life-threatening conditions using their ADAPTTM technology platform. While Aethlon has not received any prime federal grants, they have participated as a subcontractor on federal grants awarded to the University of Pittsburgh for research related to depleting exosomes to improve responses to immunotherapy in head and neck squamous cell carcinoma.
Quick answers
Who was awarded contract HHSN261201700022C?
HHSN261201700022C was awarded to Aethlon Medical Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2017.
How much is contract HHSN261201700022C worth?
The government has obligated $299,250 on HHSN261201700022C.
Was contract HHSN261201700022C competed?
The extent of competition for HHSN261201700022C was full and open competition. The government received 7 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award